India to Philippines: Pioglitazone Export Trade Route
India has recorded 182 verified shipments of Pioglitazone exported to Philippines, representing a combined trade value of $2.9M USD. This corridor is served by 20 active Indian exporters, with an average shipment value of $15.9K USD. The leading Indian exporter is AJANTA PHARMA LIMITED, which accounts for 34% of total export value with 16 shipments worth $984.5K USD. On the buying side, AJANTA PHARMA PHILIPPINES INC is the largest importer in Philippines with $984.5K USD in purchases. The top 3 suppliers — AJANTA PHARMA LIMITED, MICRO LABS LIMITED, MEDLEY PHARMACEUTICALS LIMITED — together control 72% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Philippines Pioglitazone corridor is one of India's established pharmaceutical export routes, with 182 shipments documented worth a combined $2.9M USD. The route is dominated by AJANTA PHARMA LIMITED, which alone accounts for roughly 34% of all export value, reflecting the consolidated nature of India's pioglitazone manufacturing sector.
Across 20 active suppliers, the average shipment value stands at $15.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with pioglitazone's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 27.5%, placing it at rank #5 among India's top pioglitazone export destinations globally.
On the import side, key buyers of Indian pioglitazone in Philippines include AJANTA PHARMA PHILIPPINES INC, BROWN AND BURK PHILIPPINES INC, AMBICA INTERNATIONAL CORPORATION and 20 others. AJANTA PHARMA PHILIPPINES INC is the single largest importer with 16 shipments valued at $984.5K USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ4
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#5
- Annual growth+27.5%
- Demand growth+23.0%
- Regulatory ease73/100
Top 10 Indian Pioglitazone Exporters to Philippines
Showing top 10 of 20 Indian suppliers exporting Pioglitazone to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AJANTA PHARMA LIMITED Avg $61.5K per shipment | 16 | $984.5K | 34.0% |
| 2 | MICRO LABS LIMITED Avg $26.1K per shipment | 27 | $705.7K | 24.4% |
| 3 | MEDLEY PHARMACEUTICALS LIMITED Avg $9.3K per shipment | 41 | $380.8K | 13.2% |
| 4 | MEDLEY PHARMACEUTICALS LIMITED Avg $12.7K per shipment | 17 | $216.4K | 7.5% |
| 5 | STALLION LABORATORIES PVT LTD Avg $4.5K per shipment | 29 | $130.6K | 4.5% |
| 6 | MICRO LABS LIMITED Avg $20.8K per shipment | 6 | $124.7K | 4.3% |
| 7 | Sasha Life Healthcare Avg $20.1K per shipment | 3 | $60.3K | 2.1% |
| 8 | FORTCAPS LABORATORIES PRIVATE LIMITED Avg $49.0K per shipment | 1 | $49.0K | 1.7% |
| 9 | UMEDICA LABORATORIES PRIVATE LIMITED Avg $5.1K per shipment | 9 | $46.1K | 1.6% |
| 10 | STALLION LABORATORIES PVT LTD Avg $10.9K per shipment | 4 | $43.8K | 1.5% |
This table shows the top 10 of 20 Indian companies exporting pioglitazone to Philippines, ranked by total trade value. The listed exporters are: AJANTA PHARMA LIMITED, MICRO LABS LIMITED, MEDLEY PHARMACEUTICALS LIMITED, MEDLEY PHARMACEUTICALS LIMITED , STALLION LABORATORIES PVT LTD, MICRO LABS LIMITED , Sasha Life Healthcare, FORTCAPS LABORATORIES PRIVATE LIMITED, UMEDICA LABORATORIES PRIVATE LIMITED, STALLION LABORATORIES PVT LTD . AJANTA PHARMA LIMITED is the dominant supplier with 16 shipments worth $984.5K USD, giving it a 34% market share. The top 3 suppliers together account for 72% of the total trade value on this route.
Showing top 10 of 20 total Indian exporters on the India to Philippines Pioglitazone export route.
Top 10 Pioglitazone Importers in Philippines
Showing top 10 of 23 known buyers in Philippines receiving Pioglitazone shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian pioglitazone in Philippines include AJANTA PHARMA PHILIPPINES INC, BROWN AND BURK PHILIPPINES INC, AMBICA INTERNATIONAL CORPORATION, OEP PHILIPPINES INC, AMBICA INTERNATIONAL CORPORATION , among 23 total buyers. The largest importer is AJANTA PHARMA PHILIPPINES INC, accounting for $984.5K USD across 16 shipments — representing 34% of all pioglitazone imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AJANTA PHARMA PHILIPPINES INC | 16 | $984.5K | 34.0% |
| 2 | BROWN AND BURK PHILIPPINES INC | 11 | $426.0K | 14.7% |
| 3 | AMBICA INTERNATIONAL CORPORATION | 42 | $385.1K | 13.3% |
| 4 | OEP PHILIPPINES INC | 16 | $297.7K | 10.3% |
| 5 | AMBICA INTERNATIONAL CORPORATION | 12 | $120.7K | 4.2% |
| 6 | TO THE ORDER OF. | 25 | $102.8K | 3.6% |
| 7 | Ambica International Corporation | 5 | $95.7K | 3.3% |
| 8 | BROWN AND BURK PHILIPPINES INC. | 1 | $63.2K | 2.2% |
| 9 | M/S 4LIFE HEALTHCARE INC | 3 | $60.3K | 2.1% |
| 10 | OEP PHILIPPINES INC | 4 | $59.6K | 2.1% |
Showing top 10 of 23 Pioglitazone importers in Philippines on this route.
Top 10 Pioglitazone Formulations Imported by Philippines
Showing top 10 of 141 product formulations shipped on the India to Philippines Pioglitazone route, ranked by trade value
Philippines imports a wide range of pioglitazone formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ASENZA PLUS 30/2 MG TABLETS[12060PACKx3x10=361800TABS]PIOGLITAZONE AND GLIMEPIRIDE TAB]EACH UNCOATED TAB CONT:AS PER INV — accounts for $139.4K USD across 2 shipments. There are 141 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ASENZA PLUS 30/2 MG TABLETS[12060PACKx3x10=361800TABS]PIOGLITAZONE AND GLIMEPIRIDE TAB]EACH UNCOATED TAB CONT:AS PER INV | 2 | $139.4K | 4.8% |
| 2 | ASENZA PLUS 15/2 MG TABLETS[12600PACKx3x10=378000TABS]PIOGLITAZONE AND GLIMEPIRIDE TAB]EACH UNCOATED TAB CONT:AS PER INV | 2 | $123.6K | 4.3% |
| 3 | MEDICAMENTS - PIOGLITAZONE (AS HYDROCHLO | 6 | $100.8K | 3.5% |
| 4 | TRIPRIDE 2 (GLIMEPIRIDE 2MG, PIOGLITAZONE HCL 15MG, METFORMIN HCL 500MG TABLETS)(1X10s) - TAX INVOICE NO: 705202586 DT: | 1 | $94.1K | 3.3% |
| 5 | TENELIZONE TABS 20/30 MGTENELIGLIPTIN 20MG AND PIOGLITAZONE 30 MG TABS[13005PACKX3X10=390150 TABS]EACH FILM AS PER INV | 1 | $86.0K | 3.0% |
| 6 | ASENZA PLUS 30/2 MG TABS[12960PACKx3x10=388800 TABS][PIOGLITAZONE AND GLIMEPIRIDE TABS]EACH UNCOATED TAB CONT:AS PER INV | 1 | $74.4K | 2.6% |
| 7 | ASENZA PLUS 30/2 MG TABLETS[12765PACKX3X10=382950 TABS][PIOGLITAZONE AND GLIMEPIRIDE TABS]EACH UNCOATED TABS AS PER INV | 1 | $72.2K | 2.5% |
| 8 | ASENZA PLUS 30/2 MG TABLETS[12655PACKx3x10=379650 TABS][PIOGLITAZONE AND GLIMEPIRIDE TABS]EACH UNCOATED TAB AS PER INV | 1 | $72.2K | 2.5% |
| 9 | ASENZA PLUS 30/2 MG TABS[12595PACKx3x10=377850 TABS][PIOGLITAZONE AND GLIMEPIRIDE TABS] [EACH UNCOATED TABLET AS PER INV | 1 | $70.6K | 2.4% |
| 10 | TENELIZONE TABLETS 20/30 MG [12840 PACKX3X10=385200 TABS](TENELIGLIPTIN 20MG & PIOGLITAZONE 30MG TABLETS) AS PER INVOICENOS | 1 | $67.5K | 2.3% |
Showing top 10 of 141 Pioglitazone formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 71%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 37 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's pioglitazone exports to Philippines are driven primarily by a handful of large-scale manufacturers. AJANTA PHARMA LIMITED with 16 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 20 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — AJANTA PHARMA LIMITED, MICRO LABS LIMITED, MEDLEY PHARMACEUTICALS LIMITED — together account for 72% of total trade value on this route. The average shipment value of $15.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as asenza plus 15/2 mg tablets[12600packx3x10=378000tabs]pioglitazone and glimepiride tab]each uncoated tab cont:as per inv and medicaments - pioglitazone (as hydrochlo , suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, AJANTA PHARMA PHILIPPINES INC is the largest importer with 16 shipments worth $984.5K USD — representing 34% of all pioglitazone imports from India on this route. A total of 23 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.9M
- Avg. Shipment
- $15.9K
- Suppliers
- 20
- Buyers
- 23
- Transit (Sea)
- ~34 days
- Annual Growth
- +27.5%
Related Analysis
Other Pioglitazone Routes
Unlock the Full India to Philippines Pioglitazone Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 182 shipments on this route.
Frequently Asked Questions — India to Philippines Pioglitazone Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Pioglitazone to Philippines?
The leading Indian exporters of Pioglitazone to Philippines are AJANTA PHARMA LIMITED, MICRO LABS LIMITED, MEDLEY PHARMACEUTICALS LIMITED. AJANTA PHARMA LIMITED holds the largest market share at approximately 34% of total trade value on this route.
Q What is the total value of Pioglitazone exports from India to Philippines?
India exports Pioglitazone to Philippines worth approximately $2.9M USD across 182 recorded shipments. The average value per shipment is $15.9K USD.
Q Which ports does India use to ship Pioglitazone to Philippines?
The most active port of origin is SAHAR AIR with 37 shipments. Indian exporters primarily use sea freight for this route, with 71% of shipments going by sea and 20% by air.
Q How long does shipping take from India to Philippines for Pioglitazone?
The average transit time for Pioglitazone shipments from India to Philippines is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Philippines Pioglitazone trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 27.5% with demand growth tracking at 23.0%. The route is ranked #5 among India's top Pioglitazone export destinations globally.
Q How many suppliers are active on the India to Philippines Pioglitazone route?
There are currently 20 active Indian suppliers exporting Pioglitazone to Philippines. The market is moderately concentrated with AJANTA PHARMA LIMITED accounting for 34% of total shipment value.
Q Who are the main importers of Pioglitazone from India in Philippines?
The leading importers of Indian Pioglitazone in Philippines include AJANTA PHARMA PHILIPPINES INC, BROWN AND BURK PHILIPPINES INC, AMBICA INTERNATIONAL CORPORATION, OEP PHILIPPINES INC, AMBICA INTERNATIONAL CORPORATION . AJANTA PHARMA PHILIPPINES INC is the largest buyer with 16 shipments worth $984.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Pioglitazone.
- 2.Supplier/Buyer Matching: 20 Indian exporters and 23 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 182 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
182 Verified Shipments
20 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists